Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | MAPT | P10636 | 2/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | GAA | P10253 | 1/20 | 0.48 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.48 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.48 |
| ▸ | HPGD | P15428 | 1/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.48 |
| ▸ | PNMT | P11086 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | BACE1 | P56817 | 1/20 | 0.35 |
| ▸ | MMP9 | P14780 | 2/20 | 0.33 |
| ▸ | MMP1 | P03956 | 1/20 | 0.33 |
| ▸ | MMP3 | P08254 | 1/20 | 0.33 |
| ▸ | ADAM17 | P78536 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL9789713 | 0.98 | KMT2A (0.48) | KMT2AALDH1A1MAPTKDM4EHSD17B10 | |
| Hydrochloric Acid SCHEMBL9789645 | 0.98 | KMT2A (0.48) | KMT2AALDH1A1MAPTKDM4EHSD17B10 | |
| Hydrochloric Acid SCHEMBL9789700 | 0.98 | KMT2A (0.48) | KMT2AALDH1A1MAPTKDM4EHSD17B10 | |
| SCHEMBL7979855 | 0.89 | KMT2A (0.48) | KMT2AALDH1A1MAPTKDM4EHSD17B10 | |
| SCHEMBL24184649 | 0.89 | KMT2A (0.48) | KMT2AALDH1A1MAPTKDM4EHSD17B10 | |
| Hydrochloric Acid SCHEMBL9789720 | 0.88 | KMT2A (0.47) | KMT2AALDH1A1MAPTKDM4EHSD17B10 | |
| SCHEMBL4465829 | 0.81 | EGLN1 (0.48) | KMT2AMAPTGAAPNMT | |
| SCHEMBL11363930 | 0.81 | EGLN1 (0.48) | KMT2AMAPTGAAPNMT | |
| Hydrochloric Acid SCHEMBL8383923 | 0.80 | EGLN1 (0.47) | KMT2AMAPTGAAPNMT | |
| SCHEMBL1491696 | 0.79 | KDM4E (0.56) | KMT2AALDH1A1MAPTKDM4EHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4678644-A1 | SUBSTITUTED DIHYDROTHIENOPYRIMIDINE COMPOUND, PREPARATION METHOD THEREFOR, AND USE THEREOF | Shanghai Yidi Biotechnology Co., Ltd. (CN) | 2026-01-14 | — | — | EP | disclosed |
| US-20230190939-A1 | ANTIBODY DRUG CONJUGATES COMPRISING TOXINS WITH POLAR GROUPS AND USES THEREOF | INTOCELL, INC. (KR) | 2023-06-22 | — | — | US | disclosed |
| US-20230190939-A1 | ANTIBODY DRUG CONJUGATES COMPRISING TOXINS WITH POLAR GROUPS AND USES THEREOF | INTOCELL, INC. (KR) | 2023-06-22 | — | — | US | disclosed |
| US-20230039858-A1 | COMPOSITIONS AND METHODS RELATED TO MOLECULAR CONJUGATION | INTOCELL, INC. (KR) | 2023-02-09 | — | — | US | disclosed |
| US-20220009946-A1 | FUSED HETEROCYCLIC BENZODIAZEPINE DERIVATIVES AND USES THEREOF | INTOCELL, INC. (KR) | 2022-01-13 | — | — | US | disclosed |
| WO-2021111185-A1 | COMPOSITIONS AND METHODS RELATED TO MOLECULAR CONJUGATION | INTOCELL, INC. (KR) | 2021-06-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230190939-A1 | ANTIBODY DRUG CONJUGATES COMPRISING TOXINS WITH POLAR GROUPS AND USES THEREOF | CD47, ENPP2, CD2 | KMT2A 3159/4885ALDH1A1 4468/4885MAPT 1430/4885 |
| US-20220009946-A1 | FUSED HETEROCYCLIC BENZODIAZEPINE DERIVATIVES AND USES THEREOF | GABRB2, GABRB3, GABRB1 | KMT2A 1898/4885ALDH1A1 1347/4885MAPT 1876/4885 |
| US-20230039858-A1 | COMPOSITIONS AND METHODS RELATED TO MOLECULAR CONJUGATION | FCGR2A, FCGRT, FCGR3B | KMT2A 832/4885ALDH1A1 200/4885MAPT 451/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.